Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma

Francis K Buadi, MD, Morie A. Gertz, MD, Betsy R. Laplant, MS, Alese Halvorson, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, David Dingli, MD PhD FRCP, Prashant Kapoor, MD, Wilson I Gonsalves, MD, Teresa Miceli, RN, Eva Brandes, RN, Scott L Stafford, MD, James A Martenson, MD, William J Hogan, MBChB, Shaji K. Kumar, MD

Blood (2016) 128 (22): 2267.

https://doi.org/10.1182/blood.V128.22.2267.2267

Published: 2016

Journal Articles

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Saad Sirop Kenderian, Thomas M. Habermann, William R. Macon, Kay M. Ristow, Stephen M. Ansell, Joseph P. Colgan, Patrick B. Johnston, David J. Inwards, Svetomir N. Markovic, Ivana N. Micallef, Carrie A. Thompson, Luis F. Porrata, James A. Martenson, Thomas E. Witzig, Grzegorz S. Nowakowski

Blood (2016) 127 (16): 1960–1966.

https://doi.org/10.1182/blood-2015-08-665505

Published: 2016

Journal Articles

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Saad J. Sirop, MD, Thomas M Habermann, MD, William R Macon, MD, Kay M. Ristow, Stephen M Ansell, MD, PhD, Joseph P Colgan, MD, Patrick B. Johnston, MD, PhD, David J. Inwards, MD, Svetomir N. Markovic, MD, PhD, Ivana N. Micallef, MD, Carrie Thompson, MD, Luis F. Porrata, MD, James A. Martenson, Jr., MD, James R Cerhan, MD, PhD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD

Blood (2012) 120 (21): 1525.

https://doi.org/10.1182/blood.V120.21.1525.1525

Published: 2012

Journal Articles

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Jason M. Jones, MD, Thomas M. Habermann, MD, Kay M. Ristow, Paul Kurtin, MD, Ellen McPhail, MD, Carrie A. Thompson, MD, Joseph P. Colgan, MD, Luis F. Porrata, MD, Svetomir N. Markovic, MD, PhD, Thomas E. Witzig, MD, James A. Martenson, Jr., MD, Grzegorz S. Nowakowski, MD

Blood (2011) 118 (21): 1580.

https://doi.org/10.1182/blood.V118.21.1580.1580

Published: 2011

Journal Articles

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Mustaqeem Siddiqui, MD, Luis F. Porata, MD, Kay Ristow, Thomas M. Habermann, MD, Joseph P. Colgan, MD, William L. White, MD, Thomas E. Witzig, MD, David J. Inwards, MD, Stephen M. Ansell, MD, PhD, Ivana N. Micallef, MD, Patrick B. Johnston, MD, PhD, William G. Martin, MD, James A. Martenson, MD, Scott L. Stafford, MD, Svetomir N. Markovic, MD, PhD

Blood (2005) 106 (11): 2667.

https://doi.org/10.1182/blood.V106.11.2667.2667

Published: 2005

NARROW

Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Email alerts

ASH Publications

American Society of Hematology

Bortezomib, Melphalan and Low Dose TBI Conditioning for Patients Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma

Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution

Diffuse Large B-Cell Transformation in Nodular Lymphocyte Predominant Hodgkin Lymphoma: Incidence, Risk Factors and Outcomes After a Forty-Year Experience From a Single Institution

Primary Parotid MALT Lymphoma: Clinical Characteristics and Treatment – a Single Institution Experience

Absolute Lymphocyte Count Recovery during Standard Chemotherapy Predicts Superior Survival and Is Independent of the Hasenclever Index for Hodgkin’s Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only